Ectopic growth hormone-releasing hormone secretion by a metastatic bronchial carcinoid tumor: A case with a non hypophysial intracranial tumor that shrank during long acting octreotide treatment

Pituitary

Volumn 10, Issue 3, 2007, Pages 311-319

  Fainstein Day, Patricia ^a   Frohman, Lawrence ^b   Rivello, Hernan Garcia ^a   Reubi, Jean Claude ^c   Sevlever, Gustavo ^d   Glerean, Mariela ^a   Gianotti, Tomas Fernandez ^a   Pietrani, Marcelo ^a   Rabadan, Alejandra ^a   Racioppi, Silvina ^a   Bidlingmaier, Martin ^e  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

^d FLENI   (Argentina)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Acromegaly; Ectopic acromegaly; Growth hormone releasing hormone; Long acting octreotide; Somatostatin analogs; Somatostatin receptors type 2

Indexed keywords

GONADORELIN; OCTREOTIDE; SOMATOMEDIN C; SOMATOSTATIN RECEPTOR; THYROTROPIN;

ACROMEGALY; ADULT; ARTICLE; BONE METASTASIS; BRAIN TUMOR; BRONCHUS CARCINOID; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG RESPONSE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LUNG METASTASIS; LUNG SURGERY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT DURATION;

ACROMEGALY; ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; BLOOD GLUCOSE; BRONCHIAL NEOPLASMS; CARCINOID TUMOR; CEREBELLOPONTINE ANGLE; GROWTH HORMONE-RELEASING HORMONE; HORMONES, ECTOPIC; HUMAN GROWTH HORMONE; HUMANS; LIVER; MAGNETIC RESONANCE IMAGING; MALE; OCTREOTIDE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTORS, SOMATOSTATIN; WHOLE BODY IMAGING;

EID: 35848951859     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-007-0019-9     Document Type: Article

References (38)

1. Faglia G, Arosio M, Bazzoni N (1992) Ectopic acromegaly. Endocrinol Metab Clin North Am 21:575-595
2. Melmed S (1991) Extrapituitary acromegaly. Endocrinol Metab Clin North Am 20:507-518
3. Sano T, Asa SL, Kovacs K (1988) Growth hormone-releasing hormone-producing tumors: Clinical, biochemical, and morphological manifestations. Endocr Rev 9:357-373
4. Doga M, Bonadonna S, Burattin A, Giustina A (2001) Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects. Ann Oncol 12 (Suppl. 2):S89-S94
5. Boix E, Pico A, Pinedo R, Aranda I, Kovacs K (2002) Ectopic growth hormone-releasing hormone secretion by thymic carcinoid tumour. Clin Endocrinol (Oxf) 57:131-134
6. Reuters VS, Dias EMR, Pupo MRSR, Gadelha MR (2003) Acromegaly secondary to ectopic growth hormone-releasing hormone-secreting bronchial carcinoid cured after pneumectomy. Endocrinologist 13:376-379
7. Van den Bruel A, Fevery J, Van Dorpe J, Hofland L, Bouillon R (1999) Hormonal and volumetric long term control of a growth hormone-releasing hormone-producing carcinoid tumor. J Clin Endocrinol Metab 84:3162-3169
8. Altstadt TJ, Azzarelli B, Bevering C, Edmondson J, Nelson PB (2002) Acromegaly caused by a growth hormone-releasing hormone-secreting carcinoid tumor: Case report. Neurosurgery 50:1356-1359
9. Lefebvre S, De Paepe L, Abs R, Rahier J, Selvais P, Maiter D (1995) Subcutaneous octreotide treatment of a growth hormone-releasing hormone-secreting bronchial carcinoid: Superiority of continuous versus intermittent administration to control hormonal secretion. Eur J Endocrinol 133:320-324
10. Drange MR, Melmed S (1998) Long-acting lanreotide induces clinical and biochemical remission of acromegaly caused by disseminated growth hormone-releasing hormone-secreting carcinoid. J Clin Endocrinol Metab 83:3104-3109
11. Moller DE, Moses AC, Jones K, Thorner MO, Vance ML (1989) Octreotide suppresses both growth hormone (GH) and GH-releasing hormone (GHRH) in acromegaly due to ectopic GHRH secretion. J Clin Endocrinol Metab 68:499-504
12. Barkan AL, Shenker Y, Grekin RJ, Vale WW (1988) Acromegaly from ectopic growth hormone-releasing hormone secretion by a malignant carcinoid tumor. Successful treatment with long-acting somatostatin analogue SMS 201-995. Cancer 61:221-226
13. Schopohl J, Losa M, Frey C, Wolfram G, Huber R, Permanetter W et al (1991) Plasma growth hormone (GH)-releasing hormone levels in patiens with lung carcinoma. Clin Endocrinol (Oxf) 34:463-467
14. Brar A, Brinster R, Frohman LA (1989) Immuhistochemical analysis of human growth hormone-releasing hormone gene expression in transgenic mice. Endocrinology 125:801-809
15. Korner M, Eltschinger V, Waser B, Schonbrunn A, Reubi JC (2005) Value of immunohistochemistry for somatostatin receptor subtype sst2A in cancer tissues: Lessons from the comparison of anti-sst2A antibodies with somatostatin receptor autoradiography. Am J Surg Pathol 29:1642-1651
16. Warren WH, Gould VE, Faber LP, Kittle CF, Memoli VA (1985) Neuroendocrine neoplasms of the bronchopulmonary tract. A classification of the spectrum of carcinoid to small cell carcinoma and intervening variants. J Thorac Cardiovasc Surg 89:819-825
17. Rusch VW, Klimstra DS, Venkatraman ES (1996) Molecular markers help characterize neuroendocrine lung tumors. Ann Thorac Surg 62:798-809
18. Frohman LA, Szabo M, Berelowitz M, Stachura ME (1980) Partial purification and characterization of a peptide with growth hormone-releasing activity from extrapituitary tumors in patients with acromegaly. J Clin Invest 65:43-54
19. Dayal Y, Lin HD, Tallberg K, Reichlin S, DeLellis RA, Wolfe HJ (1986) Immunocytochemical demonstration of growth hormone-releasing factor in gastrointestinal and pancreatic endocrine tumors. Am J Clin Pathol 85:13-20
20. Asa SL, Ezzat S (1998) The cytogenesis and pathogenesis of pituitary adenomas. Endoc Rev 19:798-827
21. Lamberts SWJ, van der Lely AJ, de Herder WW, Hofland LJ (1996) Octreotide. N Eng J Med 334:246-254
22. Ferjoux G, Bousquet C, Cordelier P, Benali N, Lopez F, Rochaix P, Buscail L, Susini C (2000) Signal transduction of somatostatin receptors negatively controlling cell proliferation. J Physiol (Paris) 94:205-210
23. Patel YC (1999) Somatostatin and its receptor family. Front Neuroendocrinol 20:157-198
24. Ferrante E, Pellegrini C, Bondioni S, Peverelli E, Locatelli M, Gelmini P, Luciani P, Peri A, Mantovani G, Bosari S, Beck-Peccoz P, Spada A, Lania A (2006) Octreotide promotes apoptosis in human somatotroph cells by activating somatostatin receptor type 2. Endocr Relat Cancer 13:955-962
25. Luciani P, Gelmini S, Ferrante E, Lania A, Benvenuti S, Baglioni S, Mantovani G, Cellai I, Ammannati F, Spada A, Serio M, Peri A (2005) Expression of the antiapoptotic gene seladin-1 and octreotide-induced apoptosis in growth hormone-secreting and nonfuncioning pituitary adenomas. J Clin Endocrinol Metab 90:6156-6161
26. Janson ET, Stridsberg M, Gobl A, Westin JE, Oberg K (1998) Determination of somatostatin receptor subtype 2 in carcinoid tumors by immunohistochemical investigation with somatostatin subtype 2 antibodies. Cancer Res 58:2375-2378
27. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M (1998) Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study. Science 279:563-566
28. Zatelli MC, Maffei P, Piccin D, Martini C, Rea F, Rubello D, Margutti A, Culler MD, Sicolo N, degli Uberti EC (2005) Somatostatin analogs in vitro effects in a growth hormone-releasing hormone-secreting bronchial carcinoid. J Clin Endocrinol Metab 90:2104-2109
29. Turner HE, Thornton-Jones VA, Wass JA (2004) Systematic dose-extension of octreotide LAR: The importance of individual tailoring of treatment in patients with acromegaly. Clin Endocrinol (Oxf) 61:224-231
30. Frohman LA, Downs TR, Williams TC, Heimer EP, Pan YE, Felix AM (1986) Rapid enzymatic degradation of growth hormone-releasing hormone by plasma in vitro and in vivo to a biologicall inactive, N-terminally cleaved product. J Clin Invest 78:906-913
31. Melmed S, Ziel FH, Braunstein GD, Downs T, Frohman LA (1988) Medical managemente of acromegaly due to ectopic production of growth hormone-releasing hormone by carcinoid tumor. J Clin Endocrinol Metab 67:395-399
32. Moller DE, Moses AC, Jones K, Thorner MO, Vance ML (1989) Octreotide suppresses both growth hormone(GH) and GH-releasing hormone (GHRH) in acromegaly due to ectopic secretion. J Clin Endocrinol Metab 68:499-504
33. Bolanowski M, Hos-Kudla B, Rzeszutko M, Marciniak M, Zatonska K (2006) Five year remission of GHRH secreting bronchial neuroendocrine tumor with symptoms of acromegaly. Utility of chromogranin A in monitoring of the disease. Endokrynol Pol 57:32-36
34. Othman NH, Ezzat S, Kovacs K, Horvath E, Poulin E, Smyth HS, Asa SL (2001) Growth hormone-releasing hormone (GHRH) and GHRH receptor (GHRH-R) isoform expression in ectopic acromegaly. Clin Endocrinol (Oxf) 55:135-140
35. Hlatky R, Suki D, Sawaya R (2004) Carcinoid metastasis to the brain. Cancer 101:2605-2613
36. Schmidt M, Scheidhauer K, Luyken C, Voth E, Hildenbrandt G, Klug N, Schicha H (1998) Somatostatin receptor imaging in intracranial tumors. Eur J Nucl Med 25:675-686
37. Di Girolamo S, Ottaviani F, Floris R, Bruno E, Napolitano B, Schillaci O (2005) Indium111 pentetreotide single photon emission computed tomography (In111 pentetreotide SPECT): A new technique to evaluate somatostatin receptors in chordomas. J Laryngol Otol 119:405-408
38. Ohnsmann A, Sachsenheimer W (1992) Intracerebral metastasis of a bronchial carcinoid tumor. Neurochirurgia (Stuttg) 35:160-162